-
1241
Criteria for selecting implementation science theories and frameworks: results from an international survey
Published 2017-10-01Get full text
Article -
1242
Clinical performance comparators in audit and feedback: a review of theory and evidence
Published 2019-04-01Get full text
Article -
1243
Tools for assessing health research partnership outcomes and impacts: a systematic review
Published 2023-01-01Get full text
Article -
1244
-
1245
-
1246
-
1247
-
1248
Activating Peripheral Innate Immunity Enables Safe and Effective Oncolytic Virotherapy in the Brain
Published 2017-12-01Get full text
Article -
1249
-
1250
-
1251
Positive Airway Pressure Usage in Youth with Obstructive Sleep Apnea Following Transition to Adult Health Care
Published 2022-02-01“…Indra Narang,1,2,* Tetyana Kendzerska,3,4,* Austin Heffernan,5 Uzair Malik,6 Carolina G Carvalho,7 Clodagh M Ryan8,9 1Department of Pediatrics, University of Toronto, Toronto, Canada; 2The Hospital for Sick Children, Toronto, Canada; 3Department of Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada; 4The Ottawa Hospital Research Institute, Ottawa, Canada; 5UBC, Faculty of Medicine, Vancouver, Canada; 6RCSI University of Medicine and Health Sciences, Dublin, Ireland; 7University Health Network; 8Department of Medicine, University of Toronto, Toronto, Canada; 9Sleep Research laboratory, KITE-UHN*These authors contributed equally to this workCorrespondence: Clodagh M Ryan, 9N-967 Toronto General Hospital, 585 University Ave., Toronto, Ontario, M5G 2N2, Canada, Email clodagh.ryan@uhn.caBackground: There is increasing prevalence of moderate to severe obstructive sleep apnea (OSA) in adolescents, the majority of whom receive treatment with positive airway pressure (PAP). …”
Get full text
Article -
1252
-
1253
-
1254
The Effect of Transplant Volume and Patient Case Mix on Center Variation in Kidney Transplantation Outcomes
Published 2019-09-01Get full text
Article -
1255
-
1256
-
1257
-
1258
-
1259
Characterization of a novel OTX2‐driven stem cell program in Group 3 and Group 4 medulloblastoma
Published 2018-04-01Get full text
Article -
1260